Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

USA - NASDAQ:MYRG - US55405W1045 - Common Stock

175.62 USD
-3.55 (-1.98%)
Last: 9/12/2025, 8:00:01 PM
176.6 USD
+0.98 (+0.56%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

5

MYRG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 52 industry peers in the Construction & Engineering industry. MYRG is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MYRG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

MYRG had positive earnings in the past year.
In the past year MYRG had a positive cash flow from operations.
Each year in the past 5 years MYRG has been profitable.
MYRG had a positive operating cash flow in each of the past 5 years.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

MYRG has a Return On Assets of 4.81%. This is comparable to the rest of the industry: MYRG outperforms 57.69% of its industry peers.
The Return On Equity of MYRG (13.10%) is better than 61.54% of its industry peers.
MYRG has a Return On Invested Capital of 10.00%. This is in the better half of the industry: MYRG outperforms 67.31% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MYRG is significantly below the industry average of 17.22%.
The 3 year average ROIC (8.30%) for MYRG is below the current ROIC(10.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.81%
ROE 13.1%
ROIC 10%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MYRG has a Profit Margin of 2.21%. This is comparable to the rest of the industry: MYRG outperforms 46.15% of its industry peers.
MYRG's Profit Margin has declined in the last couple of years.
MYRG has a Operating Margin (3.45%) which is in line with its industry peers.
MYRG's Operating Margin has declined in the last couple of years.
MYRG has a Gross Margin of 10.54%. This is in the lower half of the industry: MYRG underperforms 69.23% of its industry peers.
In the last couple of years the Gross Margin of MYRG has declined.
Industry RankSector Rank
OM 3.45%
PM (TTM) 2.21%
GM 10.54%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

7

2. Health

2.1 Basic Checks

MYRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MYRG has been reduced compared to 1 year ago.
MYRG has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MYRG is higher compared to a year ago.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 4.63. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
MYRG has a Altman-Z score of 4.63. This is in the better half of the industry: MYRG outperforms 73.08% of its industry peers.
MYRG has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
The Debt to FCF ratio of MYRG (0.82) is better than 82.69% of its industry peers.
MYRG has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MYRG (0.14) is better than 82.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.82
Altman-Z 4.63
ROIC/WACC1
WACC9.99%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.33 indicates that MYRG should not have too much problems paying its short term obligations.
MYRG has a Current ratio of 1.33. This is comparable to the rest of the industry: MYRG outperforms 57.69% of its industry peers.
MYRG has a Quick Ratio of 1.33. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.33, MYRG is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.04% over the past year.
Measured over the past years, MYRG shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.84% on average per year.
The Revenue has decreased by -3.80% in the past year.
Measured over the past years, MYRG shows a quite strong growth in Revenue. The Revenue has been growing by 10.17% on average per year.
EPS 1Y (TTM)64.04%
EPS 3Y-28.02%
EPS 5Y-3.84%
EPS Q2Q%286.81%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%1.38%

3.2 Future

The Earnings Per Share is expected to grow by 52.93% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYRG will show a small growth in Revenue. The Revenue will grow by 7.11% on average per year.
EPS Next Y284.06%
EPS Next 2Y112.76%
EPS Next 3Y74.52%
EPS Next 5Y52.93%
Revenue Next Year4.24%
Revenue Next 2Y5.21%
Revenue Next 3Y7.1%
Revenue Next 5Y7.11%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 36.66, which means the current valuation is very expensive for MYRG.
The rest of the industry has a similar Price/Earnings ratio as MYRG.
MYRG is valuated rather expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 20.97 indicates a rather expensive valuation of MYRG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MYRG indicates a somewhat cheap valuation: MYRG is cheaper than 76.92% of the companies listed in the same industry.
MYRG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.73.
Industry RankSector Rank
PE 36.66
Fwd PE 20.97
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYRG is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
MYRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 25.09
EV/EBITDA 15.12
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MYRG's earnings are expected to grow with 74.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y112.76%
EPS Next 3Y74.52%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (9/12/2025, 8:00:01 PM)

After market: 176.6 +0.98 (+0.56%)

175.62

-3.55 (-1.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners102.94%
Inst Owner Change-0.8%
Ins Owners1.75%
Ins Owner Change1.51%
Market Cap2.73B
Analysts83.33
Price Target214.71 (22.26%)
Short Float %4.61%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.94%
Max EPS beat(2)18.63%
EPS beat(4)4
Avg EPS beat(4)37.97%
Min EPS beat(4)9.94%
Max EPS beat(4)84.18%
EPS beat(8)4
Avg EPS beat(8)-5.33%
EPS beat(12)7
Avg EPS beat(12)1.42%
EPS beat(16)10
Avg EPS beat(16)2.72%
Revenue beat(2)2
Avg Revenue beat(2)4.77%
Min Revenue beat(2)3.99%
Max Revenue beat(2)5.55%
Revenue beat(4)2
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)5.55%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)8
Avg Revenue beat(12)3.9%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)2.78%
PT rev (3m)29.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.04%
EPS NY rev (1m)4.91%
EPS NY rev (3m)8.87%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)2.51%
Valuation
Industry RankSector Rank
PE 36.66
Fwd PE 20.97
P/S 0.79
P/FCF 25.09
P/OCF 15.76
P/B 4.67
P/tB 6.94
EV/EBITDA 15.12
EPS(TTM)4.79
EY2.73%
EPS(NY)8.37
Fwd EY4.77%
FCF(TTM)7
FCFY3.99%
OCF(TTM)11.14
OCFY6.34%
SpS222.41
BVpS37.58
TBVpS25.3
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.81%
ROE 13.1%
ROCE 14.51%
ROIC 10%
ROICexc 10.29%
ROICexgc 13.52%
OM 3.45%
PM (TTM) 2.21%
GM 10.54%
FCFM 3.15%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score6
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.82
Debt/EBITDA 0.45
Cap/Depr 97.93%
Cap/Sales 1.86%
Interest Coverage 250
Cash Conversion 93.63%
Profit Quality 142.23%
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 4.63
F-Score6
WACC9.99%
ROIC/WACC1
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.04%
EPS 3Y-28.02%
EPS 5Y-3.84%
EPS Q2Q%286.81%
EPS Next Y284.06%
EPS Next 2Y112.76%
EPS Next 3Y74.52%
EPS Next 5Y52.93%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%1.38%
Revenue Next Year4.24%
Revenue Next 2Y5.21%
Revenue Next 3Y7.1%
Revenue Next 5Y7.11%
EBIT growth 1Y74.74%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year403.96%
EBIT Next 3Y88.24%
EBIT Next 5Y62.41%
FCF growth 1Y211.75%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y40.32%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%